Check out how @OmniSeq and @RoswellPark are leveraging comprehensive immune profiling to identify potentially actio… https://t.co/cvWNUGWbB4
In case you missed it! OmniSeq's webinar," Comprehensive Genomic and Immune Profiling to Support Drug Development"… https://t.co/yXdsTSkVLk
FEBRUARY 9, 2021. 8:00 am PT, 11:00 am ET, 17:00 CET. REGISTR NOW to learn how @OmniSeq utilizes Genomic and Immune… https://t.co/sqAm2JP4Kt
OmniSeq on Thursday announced that it is collaborating with the University of Pittsburgh Medical Center (UPMC) on a… https://t.co/Drj11Uvaxq
BREAKING NEWS! OmniSeq and UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer. @UPMCHillmanCC… https://t.co/LtKegZMRx1
In case you missed us at SITC 2020 and AMP 2020 this Fall, take a look at the comprehensive research our scientists… https://t.co/mwebBkPsEm
NEW YORK - Molecular diagnostics laboratory @OmniSeq of Buffalo, New York, said this week that it has received ISO… https://t.co/LxJQVZOcrq
PRESS RELEASE: @OmniSeq has received the International Organization for Standards (ISO) 13485:2016 certification fo… https://t.co/QsR22HEv7V
Feedmore WNY: Help your WNY neighbors in need...here's how. https://t.co/BTpOdzGFHI
November is #LungCancerAwarenessMonth. NCCN® recommends biomarker testing in #lungcancer be performed via a broad,… https://t.co/vfjyp5CmaS